Skip to main content

The Bridge Between Nanotechnology and Neuroscience: Neuro-Nanomedicine

Buy Article:

$113.00 plus tax (Refund Policy)


The application of nanotechnology to the field of medicine is now at the cutting edge of scientific research. Named as Nanomedicine, this smart strategy is aimed to find new approaches for therapeutic application in the difficult-to-treat pathologies, as neurological diseases. Applied to Central Nervous System (CNS) pathologies, nanocarriers, engineered for the specific passage across the Blood-Brain Barrier (BBB), have been widely studied with stimulating and interesting results. The in vivo and in vitro experiments clearly demonstrated the potential of this kind of approach, that, now, clearly needs a higher grade of translation of the research to preclinical model of pathologies. This paper provides for an incisive description of the rationale and the development of nanomedicine applied to neuroscience, the neuro-nanomedicine.


Document Type: Review Article


Publication date: 2012-04-01

More about this publication?
  • Recent advances in nanomaterials indicates that the central nervous system (CNS) is susceptible to nanoparticle induced alterations leading to functional or structural alterations. This knowledge is currently disseminated in vast array of journals dealing with broad subject areas related to pharmacology, toxicology, neuroscience or nanosciences. Thus, there is an urgent need to collect all these diverse information related to nanoscience and brain function in one place using Journal of Nanoneuroscience for the benefit of the scientific community, researchers, health planners, health care providers, policy makers, environmentalists, biologists, chemists, and physicist in this emerging area of medical science.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more